Loss of p53 or p73 in human papillomavirus type 38 E6 and E7 transgenic mice partially restores the UV-activated cell cycle checkpoints

被引:0
|
作者
W Dong
C Arpin
R Accardi
L Gissmann
B S Sylla
J Marvel
M Tommasino
机构
[1] International Agency for Research on Cancer,
[2] World Health Organization,undefined
[3] Infections and Cancer Biology Group,undefined
[4] INSER,undefined
[5] M,undefined
[6] U851,undefined
[7] IFR128,undefined
[8] BioSciences Lyon-Gerland,undefined
[9] Université Lyon 1,undefined
[10] Deutsches Krebsforschungszentrum,undefined
来源
Oncogene | 2008年 / 27卷
关键词
HPV38; transgenic mice; ΔNp73; UV irradiation; cell cycle checkpoints;
D O I
暂无
中图分类号
学科分类号
摘要
We have previously shown that human keratinocytes expressing E6 and E7 from the cutaneous human papillomavirus (HPV) type 38 have high levels of a specific form of p53, which in turn activate the transcription of ΔNp73 gene. Expression of HPV38 E6 and E7 in mouse skin also promotes p53 and ΔNp73 accumulation. Interestingly, keratinocytes of these mice do not undergo cell cycle arrest after skin ultraviolet (UV) irradiation. Here, we provide several lines of evidence that ΔNp73 expression and lack of the UV response are directly linked. Loss of p53 gene in HPV38 E6/E7 transgenic mice abolished ΔNp73 expression and partially restored the UV-activated cell cycle checkpoints. Similarly, loss of p73, and consequently ΔNp73, led to restoration of the p53 pathways. In fact, keratinocytes of p73−/− HPV38 E6/E7 transgenic mice upon UV irradiation express high levels of p21WAF1 and are cell cycle arrested. Thus, HPV38 E6 and E7, via ΔNp73 accumulation, are able to alter the regulation of cell cycle checkpoints activated by UV radiation. These data suggest that UV and HPV may cooperate in skin carcinogenesis.
引用
收藏
页码:2923 / 2928
页数:5
相关论文
共 50 条
  • [21] P73β, unlike p53, suppresses growth and induces apoptosis of human papillomavirus E6-expressing cancer cells
    Prabhu, NS
    Somasundaram, K
    Satyamoorthy, K
    Herlyn, M
    El-Deiry, WS
    INTERNATIONAL JOURNAL OF ONCOLOGY, 1998, 13 (01) : 5 - 9
  • [22] TUMORIGENICITY BY HUMAN PAPILLOMAVIRUS TYPE-16 E6 AND E7 IN TRANSGENIC MICE CORRELATES WITH ALTERATIONS IN EPITHELIAL-CELL GROWTH AND DIFFERENTIATION
    GRIEP, AE
    HERBER, R
    JEON, S
    LOHSE, JK
    DUBIELZIG, RR
    LAMBERT, PF
    JOURNAL OF VIROLOGY, 1993, 67 (03) : 1373 - 1384
  • [23] Peptide Interactions Stabilize and Restructure Human Papillomavirus Type 16 E6 To Interact with p53
    Ansari, Tina
    Brimer, Nicole
    Vande Pol, Scott B.
    JOURNAL OF VIROLOGY, 2012, 86 (20) : 11386 - 11391
  • [24] ASSOCIATION OF HUMAN PAPILLOMAVIRUS TYPE-16 AND TYPE-18 E6 PROTEINS WITH P53
    WERNESS, BA
    LEVINE, AJ
    HOWLEY, PM
    SCIENCE, 1990, 248 (4951) : 76 - 79
  • [25] Interleukin-1 regulates interleukin-6 secretion in human oral squamous cell carcinoma in vitro:: Possible influence of p53 but not human papillomavirus E6/E7
    Woods, KV
    Adler-Storthz, S
    Clayman, GL
    Francis, GM
    Grimm, EA
    CANCER RESEARCH, 1998, 58 (14) : 3142 - 3149
  • [26] HUMAN PAPILLOMAVIRUS E6 TRANSFORMING PROTEIN ABROGATES P53 TRANSCRIPTIONAL ACTIVITY
    SINHA, J
    ANDROPHY, E
    MANSUR, CP
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1993, 100 (04) : 500 - 500
  • [27] INHIBITION OF P53 DNA-BINDING BY HUMAN PAPILLOMAVIRUS E6 PROTEINS
    LECHNER, MS
    LAIMINS, LA
    JOURNAL OF VIROLOGY, 1994, 68 (07) : 4262 - 4273
  • [28] Mapping the human papillomavirus 16 E6 binding and degradation domains in p53
    Chan, S
    Androphy, E
    Mansur, CP
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1996, 106 (04) : 289 - 289
  • [29] Human papillomavirus-induced carcinogenesis with p53 deficiency in mouse: Novel lymphomagenesis in HPV16E6E7 transgenic mice mimicking p53 defect
    Li, Q
    Yoshioka, N
    Yutsudo, M
    Inafuku, S
    Aozasa, K
    Kitamura, Y
    Aizawa, S
    Nishimune, Y
    Hakura, A
    Kondoh, G
    VIROLOGY, 1998, 252 (01) : 28 - 33
  • [30] A human papillomavirus type 18 E6/E7 transgene sensitizes mouse lens cells to human wild-type p53-mediated apoptosis
    Takafumi Nakamura
    Lisa Williams-Simons
    Heiner Westphal
    Oncogene, 1997, 14 : 2991 - 2998